+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pen Needles Market - Global Outlook & Forecast 2022-2027

  • PDF Icon


  • 325 Pages
  • August 2022
  • Region: Global
  • Arizton
  • ID: 5646770
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Pen needles are the needles that are attached to the durable or prefilled pens that the patients use to inject the medication. The pen needles are found mainly among insulin users, growth hormone users, and other self-injecting medication users.

The advancements in needle manufacturing technology have resulted in shorter and thinner needles. This has helped the vendors to reduce needle stick injuries. This even made vendors focus on thinner and thinner needles. These thinner needles are more user-friendly, progressively improving patient self-rating of injection comfort. BD (Becton, Dickinson) is one of the key innovative players and launched many revolutionary products in the pen needles segment.

Growth in the market is largely driven by the growing prevalence of the diabetic population and the favorable demand for self-injection devices. On the other hand, the preference for alternative modes of drug delivery, poor reimbursement in developing countries, and needle anxiety are expected to restrain the overall market growth. The growing preference for biosimilar drugs and emerging markets are areas of opportunity in the market.

All injector pens require single-use replaceable pen needles for each injection. The companies offer pen needles in various lengths to accommodate varying depths of subcutaneous tissue under the top of the skin. Pen needles are designed for single-use subcutaneous injection of medication and are not intended to be reused for more than one administration. The pen needles are generally manufactured with an outer protective plastic shell, which a person uses to attach the needle to the pen, and an inner plastic shell protecting the needle itself. The doctor or nurse's responsibility instructs how to attach and use needles to ensure proper use properly.


The Rising Prevalence of Diabetic Population

Diabetes prevalence in all regions is predicted to rise in the coming years due to unhealthy diets and bad lifestyle choices. The countries are increasingly putting in demand for medication in recent years, majorly the low-income countries, as the patients are more convenient with injector pens. The rising incidences of needle-stick injuries due to the high usage of 8mm syringes and lack of awareness & education in low-middle income countries are also one of the main reasons for the higher adoption of insulin pen needles.

When compared with developed countries, developing countries are more prone to diabetes. In these regions, young children are also affected by diabetes due to childhood obesity, which is a significant risk factor. In the case of developed countries, only older people get affected by diabetes. In contrast, in developing countries, individuals of the adult age and elderly persons above 65 are also prone to diabetes. One in 11 adults in the age group 0-79 is affected with diabetes, especially type-II, which is attributable to lifestyle changes.

Growing Demand for Self-Injection Devices

Devices for self-injection, chiefly pens used for the subcutaneous delivery of biopharmaceuticals, constitute a growing segment of the world of drug delivery devices. With the trend toward biological drugs that cannot be administered orally and the worldwide increase in diabetes, their importance is set to grow further in the future. With the large number of new injectables expected to enter the market in the coming years, the trend to shift treatment from the clinic to the home environment to save costs and provide more patient convenience is increasing the demand for self-injection devices. Self-injection solutions can also significantly improve the quality of care from the patient's perspective. Self-administration by the patient (e.g., using an injection pen) has several advantages. For drugs requiring a subcutaneous application, self-injection pens offer an ideal opportunity to control the time factor and reduce risk.

Technological Advancements in Pen Needles

New pen needles, which are better than the conventional ones, are being introduced to the market. These next-generation pen needles will significantly add an advantage to healthcare providers, nurses, and at-home settings. This trend states that the manufacturers are focusing on improving the traditional portfolios for pen needles. The needle-stick injuries and non-adherence to the therapies are the significant phenomenon in which the manufacturers try to minimize and deliver the medication safely to the patients. There are few manufacturers whose products are top-selling in the market. To reduce risk, those companies have improved their traditional portfolio of pen needles with technology.

Growing Demand for Safety Pen Needles

Accidental blood exposures are caused by contaminated needle sticks, sharps, or splashes and expose HCPs and non-healthcare users to the risk of serious infections. Pen needles with automatic protective safety features allow patients who are temporarily incompetent to continue self-administering drugs with assistance but without compromising healthcare provider (HCP) safety. Moreover, safety pen needles (SPNs) have been found to minimize the risk of exposure to bloodborne infections associated with needle-stick injury without any related adverse events. Safety devices are one of the most effective risk-control measures to prevent healthcare workers' exposure to injuries and infectious agents. Over 80% of NSIs can be prevented with the use of sharps with engineered sharps injury protection system.


Product Type Analysis

Based on product type, the market is segmented into standard pen needles and safety pen needles. In 2021, standard pen needles held the largest of 71.72% in the global market due to their daily usage of larger doses by diabetic patients. However, these needles are less preferred as they have a higher risk of needle-stick injury and interfere with the safe use of pen needles. Therefore, they are expected to be in low demand soon. Increasing diabetes and awareness of insulin pen use are some factors that support this segment's growth. Safety pen needles are expected to witness favorable growth during the forecast period due to technological advances in this segment and increased launches of next-generation products. These devices make it possible to minimize needle-stick injuries to patients.

Segmentation by Product Type

  • Standard Pen Needles
  • Safety Pen Needles

Needle Length Analysis

Based on needle length, it is segmented into short needles and long needles. The short needle segment accounted for the largest share of 78.30% in the global market in 2021. Amongst the short needle lengths, 4 mm-sized pen needles are most prescribed to all patients, including obese people suffering from the target disease. Patients are increasingly using the shortest and thinnest needles due to a greater comfort level offered by them as compared to injections. Moreover, their short layer helps reach the subcutaneous tissue of the patients easily.

Segmentation by Length

  • Short Length
  • Long Length

Therapy Analysis

The market is segmented on therapy into insulin and non-insulin. The insulin pen needles market accounted for the largest share of 81.20% in the global market in 2021 and is also expected to showcase lucrative growth over the forecast period. This is due to the increasing awareness about the self-administration of insulin therapy amongst type 1 and types 2 diabetes patients. In non-insulin therapy, GLP-1 and growth hormone therapy is expected to exhibit significant growth soon. This is due to its capability to minimize the blood glucose level amongst patients who have type 2 diabetes.

Segmentation by Therapy

  • Insulin
  • Non-Insulin

Distribution Channel

The global pen needles market is segmented into retail and online based on distribution channels. The retail segment accounted for the largest share of 76.96% in the global pen needles market in 2021. In the retail segment, hospitals and clinics play a major role in distributing pen needles. The retailer pharmacies prefer to collaborate with hospitals and clinics to get a huge profit as the hospitals and clinics are the first points of contact. Online distribution channels are expected to grow drastically in the coming era. The COVID-19 pandemic has opened the doors for online platforms to surge the demand for pen needles in the market.

Segmentation by Distribution Channel

  • Retail
  • Online


The Europe region is dominating the market and accounts for the share of 33.85%, followed by North America with the share of 29.65%, APAC with a share of 24.90%, Latin America with a share of 7.48%, and the Middle East & Africa region accounted for the share of 6.12% in the global market.

Segmentation by Geography

  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • North America
  • US
  • Canada
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • APAC
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Middle East & Africa
  • Turkey
  • South Africa
  • Saudi Arabia


The key companies profiled in the global pen needles market are:
  • BD
  • Braun Melsungen
  • Novo Nordisk
  • Owen Mumford
  • Ypsomed
These key players have a wide geographic presence in the region such as Europe, North America, and APAC. The market competition is based on quality, quantity, technology, safety, and price and is expected to surge in the coming years. These companies are focusing on launching next-generation products regarding the demand for self-injection devices and safety pen needles. The competition in the market is low as there are only a few key vendors in the market, and the market is not witnessing many mergers and acquisitions.

Other Prominent Vendors

  • AdvaCare Pharma
  • Allison Medical
  • GlucoRx
  • Hindustan Syringes & Medical Devices
  • Iyon Medical
  • Links Medical Products
  • MedExel
  • Medivena
  • Montméd
  • Narang Medical
  • Nipro Europe Group Companies
  • Promisemed Medical Devices
  • Simple Diagnostics
  • Terumo Europe
  • Trividia Health
  • UltiMed
  • Van Heek Medical

Strategies adopted by the market vendors

One of the key vendors, B.Braun Melsungen, is launching the second-generation needles, and other vendors are also coming up with safety needles in the market. These are largely adopted among the developed countries in the market. The increasing target population and adoption of advanced technologies like pen needles in Europe make them dominate the market. This is making the vendors focus the product launches across Europe. The major vendors continuously compete for the leading position in the market, with occasional spurts of competition coming from other local vendors.


1. How big is the global pen needle market?
2. What is the growth rate of the global pen needle market?
3. Who are the key players in the global pen needle market?
4. What are the growth enablers in the global pen needle market?
5. Which region is expected to hold the largest share by 2027?

Table of Contents

1 Research Methodology2 Research Objectives3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope of the Study
4.3.1 Market Segmentation by Product Type
4.3.2 Market Segmentation by Length
4.3.3 Market Segmentation by Therapy
4.3.4 Market Segmentation by Distribution Channel
4.3.5 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Premium Insights
7.1 Overview
7.1.1 Rising Prevalence of Diabetes
7.1.2 Growing Demand for Self-Injection Devices
7.1.3 Technological Advances in Pen Needles
7.1.4 Growing Demand for Safety Pen Needles
7.1.5 Product Type Analysis
7.1.6 Needle Length Analysis
7.1.7 Therapy Analysis
7.1.8 Distribution Channel
7.1.9 Geography Analysis
8 Introduction
8.1 Overview
9 Market Opportunities & Trends
9.1 Surge in Demand for Self-Injectable Devices
9.2 Technological Advances in Pen Needles
9.3 Growing Preference for Biosimilar Drugs
10 Market Growth Enablers
10.1 Expanding Patient Population for Chronic Diseases
10.2 Growing Demand for Safety Needles
10.3 Emergence of E-Commerce as Preferred Distribution Channel
11 Market Restraints
11.1 Reuse of Pen Needles
11.2 Needle Anxiety & Safety Issues Associated with Pen Needles
11.3 High Global Prevalence of Undiagnosed Diabetes
12 Market Landscape
12.1 Market Overview
12.2 Market Size & Forecast
12.2.1 Geography Analysis
12.2.2 Product Type Analysis
12.2.3 Length Analysis
12.2.4 Therapy Analysis
12.2.5 Distribution Channel Analysis
12.3 Five Forces Analysis
12.3.1 Threat of New Entrants
12.3.2 Bargaining Power of Suppliers
12.3.3 Bargaining Power of Buyers
12.3.4 Threat of Substitutes
12.3.5 Competitive Rivalry
13 Product Type
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Standard Pen Needles
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Standard Pen Needles Segmentation by Geography
13.4 Safety Pen Needles
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Safety Pen Needles Segmentation by Geography
14 Length
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Short Needles
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Short Needles Segmentation by Geography
14.4 Long Needles
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Long Needles Segmentation by Geography
15 Therapy
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Insulin
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.3.3 Insulin Segmentation by Geography
15.4 Non-Insulin
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.4.3 Non-Insulin Segmentation by Geography
16 Distribution Channel
16.1 Market Snapshot & Growth Engine
16.2 Market Overview
16.3 Retail
16.3.1 Market Overview
16.3.2 Market Size & Forecast
16.3.3 Retail Segmentation by Geography
16.4 Online
16.4.1 Market Overview
16.4.2 Market Size & Forecast
16.4.3 Online Segmentation by Geography
17 Geography
17.1 Geographic Overview
17.2 Market Snapshot & Growth Engine
18 Europe
18.1 Market Overview
18.2 Market Size & Forecast
18.2.1 Europe: Product Type Segmentation
18.2.2 Europe: Length Segmentation
18.2.3 Europe: Therapy Segmentation
18.2.4 Europe: Distribution Channel Segmentation
18.3 Key Countries
18.3.1 Germany: Market Size & Forecast
18.3.2 France: Market Size & Forecast
18.3.3 Uk: Market Size & Forecast
18.3.4 Italy: Market Size & Forecast
18.3.5 Spain: Market Size & Forecast
19 North America
19.1 Market Overview
19.2 Market Size & Forecast
19.2.1 North America: Product Type Segmentation
19.2.2 North America: Length Segmentation
19.2.3 North America: Therapy Segmentation
19.2.4 North America: Distribution Channel Segmentation
19.3 Key Countries
19.3.1 Us: Market Size & Forecast
19.3.2 Canada: Market Size & Forecast
20.1 Market Overview
20.2 Market Size & Forecast
20.2.1 APAC: Product Type Segmentation
20.2.2 APAC: Length Segmentation
20.2.3 APAC: Therapy Segmentation
20.2.4 APAC: Distribution Channel Segmentation
20.3 Key Countries
20.3.1 China: Market Size & Forecast
20.3.2 Japan: Market Size & Forecast
20.3.3 India: Market Size & Forecast
20.3.4 South Korea: Market Size & Forecast
20.3.5 Australia: Market Size & Forecast
21 Latin America
21.1 Market Overview
21.2 Market Size & Forecast
21.2.1 Latin America: Product Type Segmentation
21.2.2 Latin America: Length Segmentation
21.2.3 Latin America: Therapy Segmentation
21.2.4 Latin America: Distribution Channel Segmentation
21.3 Key Countries
21.3.1 Brazil: Market Size & Forecast
21.3.2 Mexico: Market Size & Forecast
21.3.3 Argentina: Market Size & Forecast
22 Middle East & Africa
22.1 Market Overview
22.2 Market Size & Forecast
22.2.1 Middle East & Africa: Product Type Segmentation
22.2.2 Middle East & Africa: Length Segmentation
22.2.3 Middle East & Africa: Therapy Segmentation
22.2.4 Middle East & Africa: Distribution Channel Segmentation
22.3 Key Countries
22.3.1 Turkey: Market Size & Forecast
22.3.2 South Africa: Market Size & Forecast
22.3.3 Saudi Arabia: Market Size & Forecast
23 Competitive Landscape
23.1 Competition Overview
23.2 Market Share Analysis
23.2.1 Bd
23.2.2 B. Braun Melsungen
23.2.3 Novo Nordisk
23.2.4 Owen Mumford
23.2.5 Ypsomed
24 Key Company Profiles
24.1 Bd
24.1.1 Business Overview
24.1.2 Product Offerings
24.1.3 Key Strategies
24.1.4 Key Strengths
24.1.5 Key Opportunities
24.2 B. Braun Melsungen
24.2.1 Business Overview
24.2.2 Product Offerings
24.2.3 Key Strategies
24.2.4 Key Strengths
24.2.5 Key Opportunities
24.3 Novo Nordisk
24.3.1 Business Overview
24.3.2 Product Offerings
24.3.3 Key Strategies
24.3.4 Key Strengths
24.3.5 Key Opportunities
24.4 Owen Mumford
24.4.1 Business Overview
24.4.2 Product Offerings
24.4.3 Key Strategies
24.4.4 Key Strengths
24.4.5 Key Opportunities
24.5 Ypsomed
24.5.1 Business Overview
24.5.2 Product Offerings
24.5.3 Key Strategies
24.5.4 Key Strengths
24.5.5 Key Opportunities
25 Other Prominent Vendors
25.1 Advacare Pharma
25.1.1 Business Overview
25.1.2 Product Offerings
25.2 Allison Medical
25.2.1 Business Overview
25.2.2 Product Offerings
25.3 Arkray
25.3.1 Business Overview
25.3.2 Product Offerings
25.4 Glucorx
25.4.1 Business Overview
25.4.2 Product Offerings
25.5 Hindustan Syringes & Medical Devices
25.5.1 Business Overview
25.5.2 Product Offerings
25.6 Htl-Strefa
25.6.1 Business Overview
25.6.2 Product Offerings
25.7 Igaku Needles
25.7.1 Business Overview
25.7.2 Product Offerings
25.8 Iyon Medical
25.8.1 Business Overview
25.8.2 Product Offerings
25.9 Links Medical Products
25.9.1 Business Overview
25.9.2 Product Offerings
25.10 Medexel
25.10.1 Business Overview
25.10.2 Product Offerings
25.11 Medivena
25.11.1 Business Overview
25.11.2 Product Offerings
25.12 Montméd
25.12.1 Business Overview
25.12.2 Product Offerings
25.13 Narang Medical
25.13.1 Business Overview
25.13.2 Product Offerings
25.14 Nipro Europe Group Companies
25.14.1 Business Overview
25.14.2 Product Offerings
25.15 Promisemed Medical Devices
25.15.1 Business Overview
25.15.2 Product Offerings
25.16 Shanghai Berpu Medical
25.16.1 Business Overview
25.16.2 Product Offerings
25.17 Simple Diagnostics
25.17.1 Business Overview
25.17.2 Product Offerings
25.18 Terumo Europe
25.18.1 Business Overview
25.18.2 Product Offerings
25.19 Trividia Health
25.19.1 Business Overview
25.19.2 Product Offerings
25.20 Ultimed
25.20.1 Business Overview
25.20.2 Product Offerings
25.21 Van Heek Medical
25.21.1 Business Overview
25.21.2 Product Offerings
25.22 Vogt Medical
25.22.1 Business Overview
25.22.2 Product Offerings
26 Quantitative Summary
26.1 Market by Product Type
26.1.1 Europe: Product Type Segmentation
26.1.2 North America: Product Type Segmentation
26.1.3 APAC: Product Type Segmentation
26.1.4 Latin America: Product Type Segmentation
26.1.5 Middle East & Africa: Product Type Segmentation
26.2 Market by Length
26.2.1 Europe: Length Segmentation
26.2.2 North America: Length Segmentation
26.2.3 APAC: Length Segmentation
26.2.4 Latin America: Length Segmentation
26.2.5 Middle East & Africa: Length Segmentation
26.3 Market by Therapy
26.3.1 Europe: Therapy Segmentation
26.3.2 North America: Therapy Segmentation
26.3.3 APAC: Therapy Segmentation
26.3.4 Latin America: Therapy Segmentation
26.3.5 Middle East & Africa: Therapy Segmentation
26.4 Market by Distribution Channel
26.4.1 Europe: Distribution Channel Segmentation
26.4.2 North America: Distribution Channel Segmentation
26.4.3 APAC: Distribution Channel Segmentation
26.4.4 Latin America: Distribution Channel Segmentation
26.4.5 Middle East & Africa: Distribution Channel Segmentation
26.5 Market by Geography
26.5.1 Standard Pen Needles Segmentation by Geography
26.5.2 Safety Pen Needles Segmentation by Geography
26.5.3 Short Needles Segmentation by Geography
26.5.4 Long Needles Segmentation by Geography
26.5.5 Insulin Segmentation by Geography
26.5.6 Non-Insulin Segmentation by Geography
26.5.7 Retail Segmentation by Geography
26.5.8 Online Segmentation by Geography
27 Report Summary
27.1 Key Takeaways
27.2 Strategic Recommendations
28 Appendix
28.1 Abbreviations

Companies Mentioned

  • BD
  • Braun Melsungen
  • Novo Nordisk
  • Owen Mumford
  • Ypsomed
  • AdvaCare Pharma
  • Allison Medical
  • GlucoRx
  • Hindustan Syringes & Medical Devices
  • Iyon Medical
  • Links Medical Products
  • MedExel
  • Medivena
  • Montméd
  • Narang Medical
  • Nipro Europe Group Companies
  • Promisemed Medical Devices
  • Simple Diagnostics
  • Terumo Europe
  • Trividia Health
  • UltiMed
  • Van Heek Medical


Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.

Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.